BACKGROUND: Health professionals have a proven, positive impact on patients' ability to quit smoking, yet few integrate cessation counseling into routine practice.The aim of this study was to evaluate the impact of continuing education training on physicians' and pharmacists' cessation counseling. METHODS: A group-randomized trial of health care providers (87 physicians and 83 pharmacists) from 16 Texas communities comparedsmoking cessation training (intervention group) with skin cancer prevention training (control group). Pretraining, posttraining, and extended follow-up surveys were collected from providers. Perceived ability, confidence, and intention (ACI) to address smoking with patients were assessed with a composite ACI index. Patient exit interviews (at baseline, 1452 patients completed interviews; after 12 months, 1303 completed interviews) assessed counseling practices. RESULTS: There was a significant increase in the percentage of physicians with a high ACI index in the intervention group from pretraining to posttraining (27% to 73%; P < .001) vs the control group (27% to 34%; P = .42) and for pharmacists (4% to 60%; P < .001) vs the control group (10% to 14%; P = .99). Similar results were seen from pretraining to extended follow-up. At baseline, fewer pharmacy patients reported being asked about smoking compared with patients seen by physicians (7% vs 33%; P = .001). There was an increase in assisting patients to quit (6% to 36%; P = .002) by physicians (baseline vs 12 months) in the intervention group, but not in the control group. CONCLUSIONS: Training led to significant and lasting improvement in counseling among physicians. Low levels of counseling were seen among pharmacists.
RCT Entities:
BACKGROUND: Health professionals have a proven, positive impact on patients' ability to quit smoking, yet few integrate cessation counseling into routine practice.The aim of this study was to evaluate the impact of continuing education training on physicians' and pharmacists' cessation counseling. METHODS: A group-randomized trial of health care providers (87 physicians and 83 pharmacists) from 16 Texas communities compared smoking cessation training (intervention group) with skin cancer prevention training (control group). Pretraining, posttraining, and extended follow-up surveys were collected from providers. Perceived ability, confidence, and intention (ACI) to address smoking with patients were assessed with a composite ACI index. Patient exit interviews (at baseline, 1452 patients completed interviews; after 12 months, 1303 completed interviews) assessed counseling practices. RESULTS: There was a significant increase in the percentage of physicians with a high ACI index in the intervention group from pretraining to posttraining (27% to 73%; P < .001) vs the control group (27% to 34%; P = .42) and for pharmacists (4% to 60%; P < .001) vs the control group (10% to 14%; P = .99). Similar results were seen from pretraining to extended follow-up. At baseline, fewer pharmacy patients reported being asked about smoking compared with patients seen by physicians (7% vs 33%; P = .001). There was an increase in assisting patients to quit (6% to 36%; P = .002) by physicians (baseline vs 12 months) in the intervention group, but not in the control group. CONCLUSIONS: Training led to significant and lasting improvement in counseling among physicians. Low levels of counseling were seen among pharmacists.
Authors: S R Cummings; R J Richard; C L Duncan; B Hansen; R Vander Martin; B Gerbert; T J Coates Journal: J Gen Intern Med Date: 1989 Nov-Dec Impact factor: 5.128
Authors: Karen Suchanek Hudmon; Kimberly Bardel; Lisa A Kroon; Christine M Fenlon; Robin L Corelli Journal: Nicotine Tob Res Date: 2005-04 Impact factor: 4.244
Authors: Karen Suchanek Hudmon; Lisa A Kroon; Robin L Corelli; Katherine C Saunders; Margaret R Spitz; Theodore R Bates; Dong Liang Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-03 Impact factor: 4.254
Authors: Matthew A Hoch; Karen Suchanek Hudmon; Linh Lee; Rebecca Cupp; Linda Aragon; Rachel A Tyree; Robin L Corelli Journal: J Community Health Date: 2012-08
Authors: Scott B Cantor; Ashish A Deshmukh; Nancy Stancic Luca; Graciela M Nogueras-González; Tanya Rajan; Alexander V Prokhorov Journal: Addict Behav Date: 2015-01-14 Impact factor: 3.913
Authors: Alan J Zillich; Robin L Corelli; Susan M Zbikowski; L Brooke Magnusson; Christine M Fenlon; Alexander V Prokhorov; Carl de Moor; Karen Suchanek Hudmon Journal: Res Social Adm Pharm Date: 2012-05-02
Authors: Robin L Corelli; Alan J Zillich; Carl de Moor; Margherita R Giuliano; Jennifer Arnold; Christine M Fenlon; Cami L Douglas; Brooke Magnusson; Susan M Zbikowski; Alexander V Prokhorov; Karen Suchanek Hudmon Journal: Res Social Adm Pharm Date: 2012-07-27
Authors: Erin P Balogh; Carolyn Dresler; Mark E Fleury; Ellen R Gritz; Thomas J Kean; Matthew L Myers; Sharyl J Nass; Brenda Nevidjon; Benjamin A Toll; Graham W Warren; Roy S Herbst Journal: Oncologist Date: 2013-12-04
Authors: Benjamin A Toll; Thomas H Brandon; Ellen R Gritz; Graham W Warren; Roy S Herbst Journal: Clin Cancer Res Date: 2013-04-09 Impact factor: 12.531
Authors: Sarah E McBane; Robin L Corelli; Christian B Albano; John M Conry; Mark A Della Paolera; Amy K Kennedy; Antoine T Jenkins; Karen Suchanek Hudmon Journal: Am J Pharm Educ Date: 2013-06-12 Impact factor: 2.047
Authors: Karen Suchanek Hudmon; Robin L Corelli; Carl de Moor; Alan J Zillich; Christine Fenlon; Lyndsay Miles; Alexander V Prokhorov; Susan M Zbikowski Journal: J Am Pharm Assoc (2003) Date: 2018-05-18